Clinical evaluation of its level (for the middle region of B-type natriuretic peptide (BNP), N-terminal proBNP, and N-terminal atrial natriuretic peptide) has become a valuable tool for diagnosing patients with heart failure and risk stratification [13, 14]. Here, NPPB is linked to heart failure.